Scope and Impact of Financial Conflicts of Interest in Biomedical Research

Масштабы и влияние финансовых конфликтов интересов в биомедицинских исследованиях
Justin E. Bekelman, Yan Li, Cary P. Gross
2003-01-22

biomedical researchfinancial conflicts of interestindustry sponsorshippro-industry conclusionspublication restrictions
CONTEXT: Despite increasing awareness about the potential impact of financial conflicts of interest on biomedical research, no comprehensive synthesis of the body of evidence relating to financial conflicts of interest has been performed. OBJECTIVE: To review original, quantitative studies on the extent, impact, and management of financial conflicts of interest in biomedical research. DATA SOURCES: Studies were identified by searching MEDLINE (January 1980-October 2002), the Web of Science citation database, references of articles, letters, commentaries, editorials, and books and by contacting experts. STUDY SELECTION: All English-language studies containing original, quantitative data on financial relationships among industry, scientific investigators, and academic institutions were included. A total of 1664 citations were screened, 144 potentially eligible full articles were retrieved, and 37 studies met our inclusion criteria. DATA EXTRACTION: One investigator (J.E.B.) extracted data from each of the 37 studies. The main outcomes were the prevalence of specific types of industry relationships, the relation between industry sponsorship and study outcome or investigator behavior, and the process for disclosure, review, and management of financial conflicts of interest. DATA SYNTHESIS: Approximately one fourth of investigators have industry affiliations, and roughly two thirds of academic institutions hold equity in start-ups that sponsor research performed at the same institutions. Eight articles, which together evaluated 1140 original studies, assessed the relation between industry sponsorship and outcome in original research. Aggregating the results of these articles showed a statistically significant association between industry sponsorship and pro-industry conclusions (pooled Mantel-Haenszel odds ratio, 3.60; 95% confidence interval, 2.63-4.91). Industry sponsorship was also associated with restrictions on publication and data sharing. The approach to managing financial conflicts varied substantially across academic institutions and peer-reviewed journals. CONCLUSIONS: Financial relationships among industry, scientific investigators, and academic institutions are widespread. Conflicts of interest arising from these ties can influence biomedical research in important ways.
1
Academic institutions and peer-reviewed journals varied substantially in their approaches to disclosing, reviewing, and managing financial conflicts of interest.
2
Across 1,140 original studies, industry sponsorship was significantly associated with pro-industry conclusions, with a pooled odds ratio of 3.60 (95% CI, 2.63-4.91).
3
Approximately one quarter of biomedical investigators have industry affiliations, while about two thirds of academic institutions hold equity in sponsoring start-ups.
4
Financial relationships among industry, investigators, and academic institutions are widespread and can materially influence biomedical research.
5
Industry sponsorship was associated with restrictions on publication and data sharing.

Financial relationships and conflicts of interest among industry, scientific investigators, and academic institutions in biomedical research

The prevalence, effects on study outcomes and investigator behavior, and disclosure, review, and management of financial conflicts of interest

Publication Details
Publication Date
2003-01-22
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Justin E. Bekelman
Yan Li
Cary P. Gross
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%